<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">spractice</journal-id><journal-title-group><journal-title xml:lang="ru">Хирургическая практика</journal-title><trans-title-group xml:lang="en"><trans-title>Surgical practice (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2223-2427</issn><publisher><publisher-name>АНО "Консорциум "Медицинская техника"</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.38181/2223-2427-2022-4-42-47</article-id><article-id custom-type="elpub" pub-id-type="custom">spractice-363</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>БЛЕББИНГ ПЛАЗМАТИЧЕСКОЙ МЕМБРАНЫ ЛИМФОЦИТОВ В ПОСЛЕОПЕРАЦИОННОМ ПЕРИОДЕ УРОЛИТИАЗА</article-title><trans-title-group xml:lang="en"><trans-title>BLEBBING OF THE PLASMA MEMBRANE OF LYMPHOCYTES IN THE POSTOPERATIVE PERIOD OF UROLITHIASIS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5330-070X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бережной</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Berezhnoy</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бережной Александр Григорьевич – к.м.н., начальник хирургического отделения</p><p>Партизана Железняка ул., д. 1, 660022, Красноярск</p><p> </p></bio><bio xml:lang="en"><p>Alexandr G. Berezhnoy – Dr. Sci., Professor Department of Urology, Andrology and Sexology</p><p>Partizan Zheleznyak Str., 1, Krasnoyarsk, 660022</p><p>Head of the Department of Urology</p><p>Lomonosova Str., 47, Krasnoyarsk, 660058</p></bio><email xlink:type="simple">malashenko_aa@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2820-4737</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дунаевская</surname><given-names>С. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Дунаевская</surname><given-names>С. С.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Дунаевская Светлана Сергеевна – д.м.н., профессор кафедры общей хирургии, руководитель кабинета координации научно-исследовательской деятельности</p><p>Партизана Железняка ул., д. 1, 660022, Красноярск</p><p>ул. Ломоносова, д. 47, 660058, Красноярск</p><p>Тел.: 89050873585</p><p> </p></bio><bio xml:lang="en"><p>Дунаевская Светлана Сергеевна – Dr. Sci., Professor Department of General Surgery, prof.</p><p>Partizan Zheleznyak Str., 1, Krasnoyarsk, 660022</p><p>Head of the Research Coordination Office</p><p>Lomonosova Str., 47, Krasnoyarsk, 660058</p><p>Tel.: 89050873585</p></bio><email xlink:type="simple">vikto-potapenk@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО КрасГМУ им. проф. В.Ф. Войно-Ясенецкого Минздрава России; Клиническая больница «РЖД-Медицина» города Красноярск</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.F. Voino-Yasenetsky Krasnoyarsk State Medical University; Road hospital at the station Krasnoyarsk Russian Railways</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>08</day><month>12</month><year>2022</year></pub-date><volume>0</volume><issue>4</issue><fpage>42</fpage><lpage>47</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Бережной А.Г., Дунаевская С.С., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Бережной А.Г., Дунаевская С.С.</copyright-holder><copyright-holder xml:lang="en">Berezhnoy A.G., Дунаевская С.С.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.spractice.ru/jour/article/view/363">https://www.spractice.ru/jour/article/view/363</self-uri><abstract><p>Мочекаменная болезнь является актуальной проблемой хирургической урологии, ежегодно на территории Российской Федерации производится порядка 200 тысяч операций. Осложненное течение послеоперационного периода сопровождается изменениями гомеостаза, связанными с активацией иммунитета и дисрегуляцией эндотелиальной системы. В исследовании проведена оценка показателей блеббинга плазматической мембраны лимфоцитов у пациентов с осложненным и неосложненным течением послеоперационного периода уролитиаза. Приняло участие 240 пациентов, которым были проведены эндоскопические и малоинвазивные вмешательства по поводу мочекаменной болезни. Для сравнения и статистической обработки данных были выделены две клинические группы пациентов: I группа (n=130), в этой группе осложнений не было, II группа (n=110) – пациенты с осложненным течением послеоперационного периода. Контрольную группу составили – 25 практически здоровых лиц. Состояние мембраны лимфоцитов оценивали методом фазово-контрастной микроскопии. Максимальная частота изменений плазматической мембраны регистрировалась у пациентов с развившемся в послеоперационном периоде осложнениями и составила 15,92 [13,20; 17,01] при оценке начального блеббинга и 21,93 [17,67; 30,45] для терминального блеббинга. При благоприятном течении послеоперационного периода у пациентов с уролитиазом не происходило статистически значимых изменений в показателях блеббинга плазматической мембраны лимфоцитов.</p></abstract><trans-abstract xml:lang="en"><p>Urolithiasis is an urgent problem of surgical urology, about 200 thousand operations are performed annually in the Russian Federation. The complicated course of the postoperative period is accompanied by changes in homeostasis associated with immune activation and dysregulation of the endothelial system. The study evaluated the parameters of lymphocyte plasma membrane blebbing in patients with complicated and uncomplicated postoperative urolithiasis. 240 patients suffering from urolithiasis took part, who underwent surgical treatment. Patients were divided into two clinical groups: I clinical group (n = 130) – patients with a favorable course of the postoperative period of urolithiasis, II clinical group (n = 110) – patients with a complicated course of the postoperative period of urolithiasis. The control group was – 25 practically healthy persons. Lymphocyte membrane status was assessed by phase contrast microscopy. The maximum frequency of plasma membrane changes was recorded in patients with postoperative complications and amounted to 15.92 [13.20; 17.01] when evaluating initial blebbing and 21.93 [17.67; 30.45] for terminal blebbing. With a favorable course of postoperative period, patients with urolithiasis did not have statistically significant changes in the parameters of blebbing of the plasma membrane of lymphocytes.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>уролитиаз</kwd><kwd>операция</kwd><kwd>послеоперационный период</kwd><kwd>лимфоцит</kwd><kwd>блеббинг</kwd></kwd-group><kwd-group xml:lang="en"><kwd>urolithiasis</kwd><kwd>surgery</kwd><kwd>postoperative period</kwd><kwd>lymphocyte</kwd><kwd>blebbing</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Акилов Ф.А., Мухтаров Ш.Т., Гиясов Ш.И., Мирхамидов Д.Х., Насиров Ф.Р., Муратова Н.Б. Послеоперационные инфекционно-воспалительные осложнения эндоскопических операций по поводу уролитиаза. Урология. 2013;1:89–91. [Akilov F.A., Mukhtarov Sh. T., Giyasov Sh. I., Mirkhamidov D.H., Nasirov F. R., Muratova N. B. Postoperative infectious and inflammatory complications of endoscopic operations for an urolitiaz. Urologiya =Urology. 2013;1:89-91 (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Акилов Ф.А., Мухтаров Ш.Т., Гиясов Ш.И., Мирхамидов Д.Х., Насиров Ф.Р., Муратова Н.Б. Послеоперационные инфекционно-воспалительные осложнения эндоскопических операций по поводу уролитиаза. Урология. 2013;1:89–91. [Akilov F.A., Mukhtarov Sh. T., Giyasov Sh. I., Mirkhamidov D.H., Nasirov F. R., Muratova N. B. Postoperative infectious and inflammatory complications of endoscopic operations for an urolitiaz. Urologiya =Urology. 2013;1:89-91 (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Marschang S., Bernardo G. Prevention and control of healthcare associated infection in Europe: a review of patients’ perspectives and existing differences. J Hosp Infect. 2015;89(4):357–62. https://doi.org/10.1016/j.jhin.2015.01.017</mixed-citation><mixed-citation xml:lang="en">Marschang S., Bernardo G. Prevention and control of healthcare associated infection in Europe: a review of patients’ perspectives and existing differences. J Hosp Infect. 2015;89(4):357–62. https://doi.org/10.1016/j.jhin.2015.01.017</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Nicolle L.E. Urinary tract in geriatric and institutionalized patients. Current Opinion in Urology. 2002;12 (1):51– 5. https://doi.org/10.1097/00042307-200201000-00010</mixed-citation><mixed-citation xml:lang="en">Nicolle L.E. Urinary tract in geriatric and institutionalized patients. Current Opinion in Urology. 2002;12 (1):51– 5. https://doi.org/10.1097/00042307-200201000-00010</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Бережной А.Г., Винник Ю.С., Дунаевская С.С., Антюфриева Д.А. Возможности прогнозирования развития воспалительных осложнений послеоперационного периода у больных с мочекаменной болезнью. Вестник новых медицинских технологий. 2019;2:109–113. [Berezhnoy A.G., Vinnik Yu.S., Dunaevskaya S.S., Antyufrieva D.A. Possibilities to predict the development of inflammatory complications of the postoperative period in patients with urolithiasis. Vestnik novykh meditsinskikh tekhnologiy=Bulletin of new medical technologies. 2019;2:109–113 (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Бережной А.Г., Винник Ю.С., Дунаевская С.С., Антюфриева Д.А. Возможности прогнозирования развития воспалительных осложнений послеоперационного периода у больных с мочекаменной болезнью. Вестник новых медицинских технологий. 2019;2:109–113. [Berezhnoy A.G., Vinnik Yu.S., Dunaevskaya S.S., Antyufrieva D.A. Possibilities to predict the development of inflammatory complications of the postoperative period in patients with urolithiasis. Vestnik novykh meditsinskikh tekhnologiy=Bulletin of new medical technologies. 2019;2:109–113 (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Каприн А.Д., Дольнов А.А. Особенности иммунитета при мочекаменной болезни. Вопросы урологии и андрологии. 2013; 1(2);46-49. [Kaprin A.D., Dolnov A.A. Features of immunity at an urolithic disease. Voprosy urologii i andrologii = Questions of urology and andrology. 2013; 1(2);46-49 (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Каприн А.Д., Дольнов А.А. Особенности иммунитета при мочекаменной болезни. Вопросы урологии и андрологии. 2013; 1(2);46-49. [Kaprin A.D., Dolnov A.A. Features of immunity at an urolithic disease. Voprosy urologii i andrologii = Questions of urology and andrology. 2013; 1(2);46-49 (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Tixeira R., Phan T.K., Caruso S., Shi B., Atkin-Smith G.K., Nedeva C., Chow J.D.Y., Puthalakath H., Hulett M.D., Herold M.J., Poon I.K.H. ROCK1 but not LIMK1 or PAK2 is a key regulator of apoptotic membrane blebbing and cell disassembly. Cell Death Differ. 2020;27(1):102-116. https://doi.org/10.1038/s41418-019-0342-5</mixed-citation><mixed-citation xml:lang="en">Tixeira R., Phan T.K., Caruso S., Shi B., Atkin-Smith G.K., Nedeva C., Chow J.D.Y., Puthalakath H., Hulett M.D., Herold M.J., Poon I.K.H. ROCK1 but not LIMK1 or PAK2 is a key regulator of apoptotic membrane blebbing and cell disassembly. Cell Death Differ. 2020;27(1):102-116. https://doi.org/10.1038/s41418-019-0342-5</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ермишина В.И., Казеко Н.И., Осколков С.А. Показатели иммунитета при осложненном хроническом пиелонефрите. Тюменский медицинский журнал. 2015;3(17):62-65. [Ermishina V.I., Kazeko N.I., Oskolkov S.A. Immunity indicators at the complicated chronic pyelonephritis. Tyumenskiy meditsinskiy zhurnal =Tyumen medical magazine. 2015;3(17):62-65 (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Ермишина В.И., Казеко Н.И., Осколков С.А. Показатели иммунитета при осложненном хроническом пиелонефрите. Тюменский медицинский журнал. 2015;3(17):62-65. [Ermishina V.I., Kazeko N.I., Oskolkov S.A. Immunity indicators at the complicated chronic pyelonephritis. Tyumenskiy meditsinskiy zhurnal =Tyumen medical magazine. 2015;3(17):62-65 (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Mobarrez F., Fuzzi E., Gunnarsson I., Larsson A., Eketjäll S., Pisetsky D.S., Svenungsson E. Microparticles in the blood of patients with SLE: Size, content of mitochondria and role in circulating immune complexes. J Autoimmun. 2019;102:142-149. https://doi.org/10.1016/j.jaut.2019.05.003</mixed-citation><mixed-citation xml:lang="en">Mobarrez F., Fuzzi E., Gunnarsson I., Larsson A., Eketjäll S., Pisetsky D.S., Svenungsson E. Microparticles in the blood of patients with SLE: Size, content of mitochondria and role in circulating immune complexes. J Autoimmun. 2019;102:142-149. https://doi.org/10.1016/j.jaut.2019.05.003</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Obeidy P., Ju L.A., Oehlers S.H., Zulkhernain N.S., Lee Q., Galeano Niño J.L., Kwan R.Y., Tikoo S., Cavanagh L.L., Mrass P., Cook A.J., Jackson S.P., Biro M., Roediger B., Sixt M., Weninger W. Partial loss of actin nucleator actin-related protein 2/3 activity triggers blebbing in primary T lymphocytes. Immunol Cell Biol. 2020;98(2):93-113. https://doi.org/10.1111/imcb.12304</mixed-citation><mixed-citation xml:lang="en">Obeidy P., Ju L.A., Oehlers S.H., Zulkhernain N.S., Lee Q., Galeano Niño J.L., Kwan R.Y., Tikoo S., Cavanagh L.L., Mrass P., Cook A.J., Jackson S.P., Biro M., Roediger B., Sixt M., Weninger W. Partial loss of actin nucleator actin-related protein 2/3 activity triggers blebbing in primary T lymphocytes. Immunol Cell Biol. 2020;98(2):93-113. https://doi.org/10.1111/imcb.12304</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Robertson T.F., Chengappa P., Gomez Atria D., Wu C.F., Avery L., Roy N.H., Maillard I., Petrie R.J., Burkhardt J.K. Lymphocyte egress signal sphingosine-1-phosphate promotes ERM-guided, bleb-based migration. J Cell Biol. 2021;220(6):e202007182. https://doi.org/10.1083/jcb.202007182</mixed-citation><mixed-citation xml:lang="en">Robertson T.F., Chengappa P., Gomez Atria D., Wu C.F., Avery L., Roy N.H., Maillard I., Petrie R.J., Burkhardt J.K. Lymphocyte egress signal sphingosine-1-phosphate promotes ERM-guided, bleb-based migration. J Cell Biol. 2021;220(6):e202007182. https://doi.org/10.1083/jcb.202007182</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Tomiyoshi G., Horita Y., Nishita M., Ohashi K., Mizuno K. Caspase-mediated cleavage and activation of LIMkinase 1 and its role in apoptotic membrane blebbing. Genes Cells. 2004;9(6):591-600. https://doi.org/10.1111/j.1356-9597.2004.00745.x</mixed-citation><mixed-citation xml:lang="en">Tomiyoshi G., Horita Y., Nishita M., Ohashi K., Mizuno K. Caspase-mediated cleavage and activation of LIMkinase 1 and its role in apoptotic membrane blebbing. Genes Cells. 2004;9(6):591-600. https://doi.org/10.1111/j.1356-9597.2004.00745.x</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
